The financing round was led by Archangel Investors to support ongoing Phase IIa trials for its lead antibiotic.
MB
MGB Biopharma
MGB Biopharma develops a novel class of anti-infectives to tackle antibiotic resistance.
Glasgow, UK—Founded 2009
MGB Biopharma is a biopharmaceutical company that develops anti-infective medications to combat antibiotic resistance.
Filed accounts
Cash at bank
Members only
Net current assets
Members only
Total assets less current liabilities
Members only
Net assets
Members only
Shareholders' funds
Members only
Fixed assets
Members only
Cash, assets and headcount from MGB Biopharma's latest Companies House filing — with year-on-year movement, free with a Winfred account.